PharmaPros Completes Business Transition, Becomes eClinical Insights

November 20, 2013

Company News Release

PharmaPros Corporation, a provider of integrated technology delivery and services for clinical trials, announced today that the company has changed its name to eClinical Insights, Inc.

PharmaPros Corporation, a provider of integrated technology delivery and services for clinical trials, announced today that the company has changed its name to eClinical Insights, Inc. The name change, which takes effect immediately, is more reflective of the company’s recent business transition from a technology-enabled services organization, to a SaaS-based software firm focused on helping pharmaceutical, biotech, medical device, and contract research organizations, improve the performance of their clinical trials.

“The transition into eClinical Insights has been a natural evolution, and has coincided with industry trends. After a decade of running clinical trials for customers, and leveraging our technology to provide best-of-breed solutions, we had a unique vantage point from which to develop software that enabled real-time collaboration and process improvement,” said Peg Regan, President and CEO of eClinical Insights. “Recognizing the impact of global expansion, increased outsourcing, and continued adoption of electronic data capture technologies was having on trial visibility, we saw an opportunity to address these challenges through a technology platform that delivers process automation, data visualization, and business analytics through the cloud.”  

After early success with flagship product Dataflow Manager, the company continued to make significant R&D investments, and worked with customers including Biogen Idec and Harvard Clinical Research Institute, to greatly expand its data integration, workflow automation, and business analytics capabilities. The result is an integrated technology platform that enables proactive management of clinical trials across disparate teams, vendors, and clinical systems, and optimizes collaboration between sponsors and CROs.

“The outsourced clinical trials landscape has significantly reduced the sponsor company's control over the performance of their trials.  As a result, CROs are being asked to provide metrics, KPIs, and trending on trial progress,” said Regan. “Our technology empowers CROs to deliver this mission critical information in real-time, and provides sponsor companies the ability to make critical business decisions using the most current and accurate information possible." 

eClinical Insights has experienced early success with the recent launch of two additional products, inTrial Metrix™ and TrialOps Director™, expanding its market penetration by adding multiple new customers to its already impressive customer list of BioPharma leaders, and clinical research organizations (CROs), and is preparing to officially launch its eClinical intelligence platform in late 2013.